Fecha de la publicación: 14/01/2020
Autor: Kerbi Alejandro Guevara-Noriega (1), Valerie Armstrong (2), Miguel Bejarano (3), Claudia Sosa-Aranguren (4), Claudia Riera-Hernandez (5), Pedro Lopez (6), Nuria Cordoba-Fernandez (7), Elena Gonzalez-Cañas 7, Jose Luis Pomar (8)
1Vascular Surgery Department, Parc Tauli University Hospital, Sabadell, Spain; General Surgery Department, Jackson Memorial Hospital, Miami, Florida. Electronic address: email@example.com.
2General Surgery Department, Jackson Memorial Hospital, Miami, Florida; University of Miami Miller School of Medicine, Miami, Florida.
3Pediatric Surgery Department, Hospital Sant Joan de Deu, Barcelona, Spain.
4Vascular Surgery Department, Hospital Universitari Joser Trueta, Girona, Spain.
5Vascular Surgery Department. Germans Trias i Pujol University Hospital, Badalona, Spain.
6Tissue Transplant, Catalan Organization of Transplants, Barcelona, Spain.
7Vascular Surgery Department, Parc Tauli University Hospital, Sabadell, Spain.
8Cardiovascular Surgery Deparment, Hospital Clinic i Provincial, Barcelona, Spain.
Background: In recent years, there have been significant changes in the perception of valvular and vascular allograft transplants. Despite the constant evolution of the field of transplant and the involvement of multiple surgical specialties, there is not an official registry for administrative and clinical control. This study aims to design a registry of vascular and valvular allograft transplantation in Catalonia, Spain (ReVAC).
Materials and methods: Three consecutive focal groups were designed. Focal groups established administrative, technical, and clinical requirements of ReVAC. ReVAC included patients with a transplanted cryopreserved vascular segment or cardiac valves that were distributed by Catalan tissue banks to public and private hospitals in Catalonia. Ten hospitals were involved in this study. Data were collected on 380 patients between January 1995 and November 2015.
Results: The project resulted in the completion of a growing platform available online. ReVAC was divided into the following 3 levels: patient-related, surgery-related, and transplant-related data. Online access is available through the website of applications of the «Generalitat de Catalunya.»
Conclusion: ReVAC has been useful for administrative and clinical control of transplants in Catalonia. Currently, data related to outcomes of arterial allografts are available, reinforcing the current guideline-supported indications, as well as opening a window for further analysis and guideline creation.
Copyright © 2019 Elsevier Inc. All rights reserved.